Your browser doesn't support javascript.
loading
Author Correction: Codon-specific translation reprogramming promotes resistance to targeted therapy.
Rapino, Francesca; Delaunay, Sylvain; Rambow, Florian; Zhou, Zhaoli; Tharun, Lars; De Tullio, Pascal; Sin, Olga; Shostak, Kateryna; Schmitz, Sebastian; Piepers, Jolanda; Ghesquière, Bart; Karim, Latifa; Charloteaux, Benoit; Jamart, Diane; Florin, Alexandra; Lambert, Charles; Rorive, Andrée; Jerusalem, Guy; Leucci, Eleonora; Dewaele, Michael; Vooijs, Marc; Leidel, Sebastian A; Georges, Michel; Voz, Marianne; Peers, Bernard; Büttner, Reinhard; Marine, Jean-Christophe; Chariot, Alain; Close, Pierre.
Afiliação
  • Rapino F; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.
  • Delaunay S; GIGA-institute, University of Liège, Liège, Belgium.
  • Rambow F; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.
  • Zhou Z; GIGA-institute, University of Liège, Liège, Belgium.
  • Tharun L; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • De Tullio P; Center for Cancer Biology, VIB, Leuven, Belgium.
  • Sin O; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.
  • Shostak K; GIGA-institute, University of Liège, Liège, Belgium.
  • Schmitz S; Institute for Pathology, University Hospital Cologne, Cologne, Germany.
  • Piepers J; Centre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.
  • Ghesquière B; Max Planck Research Group for RNA Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
  • Karim L; Faculty of Medicine, University of Münster, Münster, Germany.
  • Charloteaux B; Cells-in-Motion Cluster of Excellence, University of Münster, Münster, Germany.
  • Jamart D; GIGA-institute, University of Liège, Liège, Belgium.
  • Florin A; Laboratory of Medical Chemistry, University of Liège, Liège, Belgium.
  • Lambert C; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.
  • Rorive A; GIGA-institute, University of Liège, Liège, Belgium.
  • Jerusalem G; Department of Radiotherapy (MAASTRO)/GROW, School for Developmental Biology and Oncology, Maastricht University, Maastricht, The Netherlands.
  • Leucci E; Metabolomics Core Facility, Center for Cancer Biology, VIB, Leuven, Belgium.
  • Dewaele M; GIGA-institute, University of Liège, Liège, Belgium.
  • Vooijs M; Unit of Animal Genomics, University of Liège, Liège, Belgium.
  • Leidel SA; GIGA-institute, University of Liège, Liège, Belgium.
  • Georges M; Unit of Animal Genomics, University of Liège, Liège, Belgium.
  • Voz M; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.
  • Peers B; GIGA-institute, University of Liège, Liège, Belgium.
  • Büttner R; Institute for Pathology, University Hospital Cologne, Cologne, Germany.
  • Marine JC; GIGA-institute, University of Liège, Liège, Belgium.
  • Chariot A; Medical Oncology, CHU Sart Tilman Liège, University of Liège, Liège, Belgium.
  • Close P; Medical Oncology, CHU Sart Tilman Liège, University of Liège, Liège, Belgium.
Nature ; 599(7886): E14, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34764478
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article